Human Gene SCN1A (ENST00000375405.7) from GENCODE V44
  Description: Homo sapiens sodium voltage-gated channel alpha subunit 1 (SCN1A), transcript variant 8, mRNA. (from RefSeq NM_001353951)
RefSeq Summary (NM_001165963): Voltage-dependent sodium channels are heteromeric complexes that regulate sodium exchange between intracellular and extracellular spaces and are essential for the generation and propagation of action potentials in muscle cells and neurons. Each sodium channel is composed of a large pore-forming, glycosylated alpha subunit and two smaller beta subunits. This gene encodes a sodium channel alpha subunit, which has four homologous domains, each of which contains six transmembrane regions. Allelic variants of this gene are associated with generalized epilepsy with febrile seizures and epileptic encephalopathy. Alternative splicing results in multiple transcript variants. The RefSeq Project has decided to create four representative RefSeq records. Three of the transcript variants are supported by experimental evidence and the fourth contains alternate 5' untranslated exons, the exact combination of which have not been experimentally confirmed for the full-length transcript. [provided by RefSeq, Oct 2015]. Sequence Note: The RefSeq transcript and protein were derived from genomic sequence to make the sequence consistent with the reference genome assembly. The genomic coordinates used for the transcript record were based on alignments.
Gencode Transcript: ENST00000375405.7
Gencode Gene: ENSG00000144285.23
Transcript (Including UTRs)
   Position: hg38 chr2:165,989,163-166,073,639 Size: 84,477 Total Exon Count: 26 Strand: -
Coding Region
   Position: hg38 chr2:165,991,245-166,073,621 Size: 82,377 Coding Exon Count: 26 

Page IndexSequence and LinksUniProtKB CommentsPrimersMalaCardsCTD
RNA-Seq ExpressionMicroarray ExpressionRNA StructureProtein StructureOther SpeciesGO Annotations
mRNA DescriptionsPathwaysOther NamesGeneReviewsMethods
Data last updated at UCSC: 2023-08-18 00:09:47

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr2:165,989,163-166,073,639)mRNA (may differ from genome)Protein (1998 aa)
Gene SorterGenome BrowserOther Species FASTAGene interactionsTable SchemaAlphaFold
BioGPSEnsemblEntrez GeneExonPrimerGencodeGeneCards
HGNCLynxMalacardsMGImyGene2neXtProt
OMIMPubMedReactomeUniProtKBWikipediaBioGrid CRISPR DB

-  Comments and Description Text from UniProtKB
  ID: SCN1A_HUMAN
DESCRIPTION: RecName: Full=Sodium channel protein type 1 subunit alpha; AltName: Full=Sodium channel protein brain I subunit alpha; AltName: Full=Sodium channel protein type I subunit alpha; AltName: Full=Voltage-gated sodium channel subunit alpha Nav1.1;
FUNCTION: Mediates the voltage-dependent sodium ion permeability of excitable membranes. Assuming opened or closed conformations in response to the voltage difference across the membrane, the protein forms a sodium-selective channel through which Na(+) ions may pass in accordance with their electrochemical gradient.
SUBUNIT: The sodium channel consists of a large polypeptide and 2- 3 smaller ones. This sequence represents a large polypeptide. Interacts with FGF13; may regulate SCN1A activity.
SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
DOMAIN: The sequence contains 4 internal repeats, each with 5 hydrophobic segments (S1,S2,S3,S5,S6) and one positively charged segment (S4). Segments S4 are probably the voltage-sensors and are characterized by a series of positively charged amino acids at every third position.
DISEASE: Defects in SCN1A are the cause of generalized epilepsy with febrile seizures plus type 2 (GEFS+2) [MIM:604403]. Generalized epilepsy with febrile seizures-plus refers to a rare autosomal dominant, familial condition with incomplete penetrance and large intrafamilial variability. Patients display febrile seizures persisting sometimes beyond the age of 6 years and/or a variety of afebrile seizure types. GEFS+ is a disease combining febrile seizures, generalized seizures often precipitated by fever at age 6 years or more, and partial seizures, with a variable degree of severity.
DISEASE: Defects in SCN1A are a cause of severe myoclonic epilepsy in infancy (SMEI) [MIM:607208]; also called Dravet syndrome. SMEI is a rare disorder characterized by generalized tonic, clonic, and tonic-clonic seizures that are initially induced by fever and begin during the first year of life. Later, patients also manifest other seizure types, including absence, myoclonic, and simple and complex partial seizures. Psychomotor development delay is observed around the second year of life. SMEI is considered to be the most severe phenotype within the spectrum of generalized epilepsies with febrile seizures-plus.
DISEASE: Defects in SCN1A are a cause of intractable childhood epilepsy with generalized tonic-clonic seizures (ICEGTC) [MIM:607208]. ICEGTC is a disorder characterized by generalized tonic-clonic seizures beginning usually in infancy and induced by fever. Seizures are associated with subsequent mental decline, as well as ataxia or hypotonia. ICEGTC is similar to SMEI, except for the absence of myoclonic seizures.
DISEASE: Defects in SCN1A are the cause of familial hemiplegic migraine type 3 (FHM3) [MIM:609634]. FHM3 is an autosomal dominant severe subtype of migraine with aura characterized by some degree of hemiparesis during the attacks. The episodes are associated with variable features of nausea, vomiting, photophobia, and phonophobia. Age at onset ranges from 6 to 15 years. FHM is occasionally associated with other neurologic symptoms such as cerebellar ataxia or epileptic seizures. A unique eye phenotype of elicited repetitive daily blindness has also been reported to be cosegregating with FHM in a single Swiss family.
DISEASE: Defects in SCN1A are the cause of familial febrile convulsions type 3A (FEB3A) [MIM:604403]; also known as familial febrile seizures 3. Febrile convulsions are seizures associated with febrile episodes in childhood without any evidence of intracranial infection or defined pathologic or traumatic cause. It is a common condition, affecting 2-5% of children aged 3 months to 5 years. The majority are simple febrile seizures (generally defined as generalized onset, single seizures with a duration of less than 30 minutes). Complex febrile seizures are characterized by focal onset, duration greater than 30 minutes, and/or more than one seizure in a 24 hour period. The likelihood of developing epilepsy following simple febrile seizures is low. Complex febrile seizures are associated with a moderately increased incidence of epilepsy.
SIMILARITY: Belongs to the sodium channel (TC 1.A.1.10) family. Nav1.1/SCN1A subfamily.
SIMILARITY: Contains 1 IQ domain.
WEB RESOURCE: Name=GeneReviews; URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/SCN1A";

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  MalaCards Disease Associations
  MalaCards Gene Search: SCN1A
Diseases sorted by gene-association score: epileptic encephalopathy, early infantile, 6* (1606), migraine, familial hemiplegic, 3* (1330), epilepsy, generalized, with febrile seizures plus, type 2* (1200), febrile seizures* (465), idiopathic generalized epilepsy* (448), focal epilepsy* (434), lennox-gastaut syndrome* (381), familial or sporadic hemiplegic migraine* (350), seizure disorder* (295), generalized epilepsy with febrile seizures plus* (285), febrile seizures, familial, 11* (283), epilepsy, generalized, with febrile seizures plus, type 1* (283), malignant migrating partial seizures of infancy* (213), epileptic encephalopathy, early infantile, 15* (186), west syndrome* (181), familial hemiplegic migraine* (138), scn1a-related seizure disorders* (100), visual epilepsy* (89), epilepsy with generalized tonic-clonic seizures (50), encephalopathy (42), epilepsy (32), myoclonic astatic epilepsy (28), early myoclonic encephalopathy (22), infancy electroclinical syndrome (20), myoclonic epilepsy of infancy (20), genetic epilepsy with febrile seizures plus (19), headache (14), migraine with aura (14), hemiplegic migraine (13), febrile infection-related epilepsy syndrome (13), sporadic hemiplegic migraine (10), rasmussen encephalitis (10), status epilepticus (10), migraine with or without aura 1 (10), hepatic coma (9), hemiplegia (9), infantile epileptic encephalopathy (8), exanthema subitum (7), epilepsy, nocturnal frontal lobe, 1 (7), epilepsy, generalized, with febrile seizures plus, type 5 (6), epileptic encephalopathy, early infantile, 9 (6), neonatal period electroclinical syndrome (5), adolescence-adult electroclinical syndrome (5), cranioectodermal dysplasia 1 (3), autism spectrum disorder (2), nervous system disease (1)
* = Manually curated disease association

-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene           more ... click here to view the complete list

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 10.68 RPKM in Brain - Frontal Cortex (BA9)
Total median expression: 62.32 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  mRNA Secondary Structure of 3' and 5' UTRs
 
RegionFold EnergyBasesEnergy/Base
Display As
5' UTR -0.6018-0.033 Picture PostScript Text
3' UTR -490.402082-0.236 Picture PostScript Text

The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.

-  Protein Domain and Structure Information
  InterPro Domains: Graphical view of domain structure
IPR024583 - DUF3451
IPR005821 - Ion_trans_dom
IPR000048 - IQ_motif_EF-hand-BS
IPR008051 - Na_channel_a1su
IPR001696 - Na_channel_asu
IPR010526 - Na_trans_assoc

Pfam Domains:
PF11933 - Cytoplasmic domain of voltage-gated Na+ ion channel
PF00520 - Ion transport protein
PF06512 - Sodium ion transport-associated

ModBase Predicted Comparative 3D Structure on P35498
FrontTopSide
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
Genome BrowserGenome BrowserNo orthologNo orthologNo orthologNo ortholog
Gene Details     
Gene Sorter     
MGIRGD    
Protein SequenceProtein Sequence    
AlignmentAlignment    

-  Gene Ontology (GO) Annotations with Structured Vocabulary
  Molecular Function:
GO:0005216 ion channel activity
GO:0005244 voltage-gated ion channel activity
GO:0005248 voltage-gated sodium channel activity
GO:0005272 sodium channel activity

Biological Process:
GO:0001508 action potential
GO:0006811 ion transport
GO:0006814 sodium ion transport
GO:0007628 adult walking behavior
GO:0019227 neuronal action potential propagation
GO:0019228 neuronal action potential
GO:0034220 ion transmembrane transport
GO:0034765 regulation of ion transmembrane transport
GO:0035725 sodium ion transmembrane transport
GO:0042391 regulation of membrane potential
GO:0050884 neuromuscular process controlling posture
GO:0050966 detection of mechanical stimulus involved in sensory perception of pain
GO:0055085 transmembrane transport
GO:0086002 cardiac muscle cell action potential involved in contraction
GO:0086010 membrane depolarization during action potential

Cellular Component:
GO:0001518 voltage-gated sodium channel complex
GO:0005654 nucleoplasm
GO:0005886 plasma membrane
GO:0014704 intercalated disc
GO:0016020 membrane
GO:0016021 integral component of membrane
GO:0016604 nuclear body
GO:0030018 Z disc
GO:0030315 T-tubule
GO:0030424 axon
GO:0033268 node of Ranvier
GO:0034706 sodium channel complex
GO:0043025 neuronal cell body
GO:0043194 axon initial segment


-  Descriptions from all associated GenBank mRNAs
  AF225985 - Homo sapiens voltage-gated sodium channel alpha subunit SCN1A (SCN1A) mRNA, complete cds.
AY043484 - Homo sapiens voltage-gated sodium channel type I mRNA, complete cds.
AB093548 - Homo sapiens SCN1A mRNA for voltage-gated sodium channel alpha1 subunit, complete cds.
AB093549 - Homo sapiens SCN1A mRNA for Voltage-gated sodium channel alpha1 subunit, complete cds, isoform type.
AB098335 - Homo sapiens SCN1A mRNA for Voltage-gated sodium channel alpha 1 subunit, complete cds.
BC172767 - Synthetic construct Homo sapiens clone IMAGE:9094253 sodium channel, voltage-gated, type I, alpha (SCN1A) gene, partial cds.
MA880531 - JP 2019501892-A/4: COMPOSITIONS AND METHODS FOR TREATMENT OF AUTOSOMAL DOMINANT MENTAL RETARDATION 5 AND DRAVET SYNDROME.
MA880533 - JP 2019501892-A/6: COMPOSITIONS AND METHODS FOR TREATMENT OF AUTOSOMAL DOMINANT MENTAL RETARDATION 5 AND DRAVET SYNDROME.
MA880534 - JP 2019501892-A/7: COMPOSITIONS AND METHODS FOR TREATMENT OF AUTOSOMAL DOMINANT MENTAL RETARDATION 5 AND DRAVET SYNDROME.
MA880532 - JP 2019501892-A/5: COMPOSITIONS AND METHODS FOR TREATMENT OF AUTOSOMAL DOMINANT MENTAL RETARDATION 5 AND DRAVET SYNDROME.
LY601186 - KR 1020180093977-A/4: ANTISENSE OLIGOMERS FOR TREATMENT OF AUTOSOMAL DOMINANT MENTAL RETARDATION-5 AND DRAVET SYNDROME.
LY601188 - KR 1020180093977-A/6: ANTISENSE OLIGOMERS FOR TREATMENT OF AUTOSOMAL DOMINANT MENTAL RETARDATION-5 AND DRAVET SYNDROME.
LY601189 - KR 1020180093977-A/7: ANTISENSE OLIGOMERS FOR TREATMENT OF AUTOSOMAL DOMINANT MENTAL RETARDATION-5 AND DRAVET SYNDROME.
LY601187 - KR 1020180093977-A/5: ANTISENSE OLIGOMERS FOR TREATMENT OF AUTOSOMAL DOMINANT MENTAL RETARDATION-5 AND DRAVET SYNDROME.
AK094487 - Homo sapiens cDNA FLJ37168 fis, clone BRACE2027767.
JD305592 - Sequence 286616 from Patent EP1572962.
JD197570 - Sequence 178594 from Patent EP1572962.
JD196904 - Sequence 177928 from Patent EP1572962.
AK294900 - Homo sapiens cDNA FLJ56968 complete cds, highly similar to Sodium channel protein type 1 subunit alpha.
AK293759 - Homo sapiens cDNA FLJ58789 complete cds, highly similar to Sodium channel protein type 1 subunit alpha.
BC172798 - Synthetic construct Homo sapiens clone IMAGE:9094284 sodium channel, voltage-gated, type I, alpha (SCN1A) gene, partial cds.
M91803 - Human sodium channel mRNA.
X65362 - Homo sapiens mRNA for brain type I sodium channel alpha-subunit (SCN1A).
HQ726796 - Homo sapiens isolate usm_gefs0209 sodium channel voltage gated type 1 alpha subunit transcript variant 2 (SCN1A) mRNA, exon 26 and partial cds.
HQ726795 - Homo sapiens isolate usm_gefs0109 sodium channel voltage gated type 1 alpha subunit transcript variant 2 (SCN1A) mRNA, exon 25 and partial cds.
HQ726799 - Homo sapiens isolate usm_gefs0310 sodium channel voltage gated type 1 alpha subunit transcript variant 2 (SCN1A) mRNA, partial cds.
HQ726798 - Homo sapiens isolate usm_gefs0210 sodium channel voltage gated type 1 alpha subunit transcript variant 2 (SCN1A) mRNA, exons 8, 9 and partial cds.
HQ726797 - Homo sapiens isolate usm_gefs0110 sodium channel voltage gated type 1 alpha subunit transcript variant 2 (SCN1A) mRNA, exons 7, 8 and partial cds.
EU368119 - Homo sapiens clone h3u voltage-gated sodium channel type I (SCN1A) mRNA, exon 3, 5' UTR and partial cds.

-  Biochemical and Signaling Pathways
  Reactome (by CSHL, EBI, and GO)

Protein P35498 (Reactome details) participates in the following event(s):

R-HSA-373739 Ankyrins link voltage-gated sodium and potassium channels to spectrin and L1
R-HSA-5576895 SCNAs:SNCBs transport Na+ from extracellular region to cytosol
R-HSA-445095 Interaction between L1 and Ankyrins
R-HSA-5576892 Phase 0 - rapid depolarisation
R-HSA-373760 L1CAM interactions
R-HSA-5576891 Cardiac conduction
R-HSA-422475 Axon guidance
R-HSA-397014 Muscle contraction
R-HSA-1266738 Developmental Biology

-  Other Names for This Gene
  Alternate Gene Symbols: ENST00000375405.1, ENST00000375405.2, ENST00000375405.3, ENST00000375405.4, ENST00000375405.5, ENST00000375405.6, NAC1, NM_001353951, P35498, Q16172, Q585T7, Q96LA3, Q9C008, SCN1, SCN1A_HUMAN, uc061peu.1
UCSC ID: ENST00000375405.7
RefSeq Accession: NM_001165963
Protein: P35498 (aka SCN1A_HUMAN or CIN1_HUMAN)
CCDS: CCDS33316.1, CCDS54413.1, CCDS54414.1

-  GeneReviews for This Gene
  GeneReviews article(s) related to gene SCN1A:
fhm (Familial Hemiplegic Migraine)
gefs (SCN1A-Related Seizure Disorders)

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.